These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12040675)
1. [Phase II study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage I c-IV ovarian cancer--KCOG 989 trial]. Nakata Y; Yamada T; Itoh R; Koishi K; Hiraoka K; Yamagami K; Itani Y; Toyoda S; Itoh K; Kimura T; Hosokawa K; Honjo H; Fujita H; Koshiba H; Hara Y; Tsuchiya H; Adachi S Gan To Kagaku Ryoho; 2002 May; 29(5):717-22. PubMed ID: 12040675 [TBL] [Abstract][Full Text] [Related]
2. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial. Fennelly D; Wasserheit C; Schneider J; Hakes T; Reich L; Curtin J; Yao TJ; Markman M; Norton L; Crown J Cancer Res; 1994 Dec; 54(23):6137-42. PubMed ID: 7525055 [TBL] [Abstract][Full Text] [Related]
4. [Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)]. Yasuda M; Kimura E; Ochiai K; Tada S; Udagawa Y; Aoki D; Nozawa S; Kikuchi Y; Kita T; Nishida M; Tsunoda H Gan To Kagaku Ryoho; 2001 Apr; 28(4):493-8. PubMed ID: 11329783 [TBL] [Abstract][Full Text] [Related]
5. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study]. Misawa A; Yasuda M Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235 [TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer. Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878 [TBL] [Abstract][Full Text] [Related]
7. [Phase I study of biweekly paclitaxel and carboplatin administration in patients with advanced non-small cell lung cancer]. Ichiki M; Rikimaru T; Gohara R; Oshita Y; Kamimura T; Hoashi S; Koga T; Aizawa H Gan To Kagaku Ryoho; 2002 Aug; 29(8):1389-94. PubMed ID: 12214466 [TBL] [Abstract][Full Text] [Related]
8. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601 [TBL] [Abstract][Full Text] [Related]
9. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318 [TBL] [Abstract][Full Text] [Related]
10. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer. Yamamoto R; Kaneuchi M; Nishiya M; Todo Y; Takeda M; Okamoto K; Negishi H; Sakuragi N; Fujimoto S; Hirano T Cancer Chemother Pharmacol; 2002 Aug; 50(2):137-42. PubMed ID: 12172979 [TBL] [Abstract][Full Text] [Related]
12. [Paclitaxel plus carboplatin in ovarian cancer-comparison of adverse effects between monthly and weekly administration]. Kumagai M; Fujii T; Komatsu M; Kusuda T; Takehara K; Shinkou S; Naitou H Gan To Kagaku Ryoho; 2004 Apr; 31(4):555-9. PubMed ID: 15114699 [TBL] [Abstract][Full Text] [Related]
13. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer. Balbi GC; Menditto A; Calabria G; Musone R; Di Prisco L; Cassese E; Balbi C; Cardone A Panminerva Med; 2001 Dec; 43(4):263-5. PubMed ID: 11677421 [TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer. Yamamoto R; Minobe S; Kaneuchi M; Sakuragi N; Fujimoto S; Ishizaki Y; Domon H; Hareyama H; Sato C; Fujino T; Kawaguchi I; Yamaguchi T; Fujimoto T; Yoshiaki K Jpn J Clin Oncol; 2002 Apr; 32(4):128-34. PubMed ID: 12072422 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer. Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567 [TBL] [Abstract][Full Text] [Related]
17. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC). Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646 [TBL] [Abstract][Full Text] [Related]
18. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial. Ichiki M; Kawasaki M; Takayama K; Ninomiya K; Kuba M; Iwami F; Miyazaki N; Oishi K; Takeo S; Aizawa H; Nakanishi Y Cancer Chemother Pharmacol; 2006 Sep; 58(3):368-73. PubMed ID: 16395589 [TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Bell J; Brady MF; Young RC; Lage J; Walker JL; Look KY; Rose GS; Spirtos NM; Gynecol Oncol; 2006 Sep; 102(3):432-9. PubMed ID: 16860852 [TBL] [Abstract][Full Text] [Related]
20. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]